Octan-2-sulphate degradation in the isolated perfused rat liver.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6712710)

Published in Biochem Pharmacol on March 01, 1984

Authors

J L Maggs, G M Powell, A H Olavesen, C G Curtis

Articles by these authors

The problem of college drinking: insights from a developmental perspective. Alcohol Clin Exp Res (2001) 2.01

The distribution of 35S-labelled sulphuric acid esters administered to mice and rats. Biochem Pharmacol (1967) 1.94

The metabolism of potassium dodecyl [35-S]sulphate in the rat. Biochem J (1969) 1.84

The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol (1987) 1.63

The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters. Biochem Pharmacol (1969) 1.51

The natural history of obstetrical brachial plexus palsy. Plast Reconstr Surg (1994) 1.49

The glycosulphatase of Trichoderma viride. Biochem J (1968) 1.47

Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry (1974) 1.40

An approach to obstetrical brachial plexus injuries. Hand Clin (1995) 1.36

The degradation of intravenously injected chondroitin 4-sulphate in the rat. Biochem J (1973) 1.33

An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br J Clin Pharmacol (1988) 1.29

Fibrin-stabilizing factor (factor XIII). Methods Enzymol (1976) 1.29

Studies on l-tyrosine O-sulphate. 1. Preparation and properties of potassium p-hydroxyphenylpyruvic acid [S]sulphate. Biochem J (1963) 1.20

Secondary structure of chondroitin sulphate in dimethyl sulphoxide. Eur J Biochem (1983) 1.20

Obstetrical brachial plexus palsy: results following neurolysis of conducting neuromas-in-continuity. Plast Reconstr Surg (1996) 1.17

Measurement of cortisol metabolites in faeces of ruminants. Vet Res Commun (2002) 1.16

The metabolism of dipotassium 2-hydroxy-5-nitrophenyl [S]sulphate, a substrate for lysosomal arylsulphatases A and B. Biochem J (1967) 1.13

Secondary structures of hyaluronate and chondroitin sulphates. A 1H n.m.r. study of NH signals in dimethyl sulphoxide solution. Biochem J (1981) 1.09

Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Pharmacol (1998) 1.09

Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther (1996) 1.06

Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen. Biochem Biophys Res Commun (1974) 1.05

Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects. Biochemistry (1981) 1.03

Titration and subunit localization of active center cysteine in fibrinoligase (thrombin-activated fibrin stabilizing fector). Biochem Biophys Res Commun (1973) 1.03

Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol (2010) 1.02

Ca2+-related regulatory function of fibrinogen. Proc Natl Acad Sci U S A (1978) 1.02

An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun (2001) 1.00

Biochemical and cellular mechanisms of dust-induced lung fibrosis. Environ Health Perspect (1984) 0.99

A model system for investigating the biliary excretion of an anion in the rat. Biochem J (1975) 0.99

Metabolism of dodecyl sulphate in the rat: non-enzymic liberation of sulphate and gamma-butyroactone from the major metabolite, butyric acid 4-sulphate. Life Sci II (1970) 0.99

Oxidation of sodium sulphide by rat liver, lungs and kidney. Biochem Pharmacol (1980) 0.98

Metabolism of sodium oestrone ( 35 S)sulphate in the rat. Biochem J (1971) 0.98

The metabolic fate of N-acetyl-D-[1-14C]galactosamine in isolated perfused rat liver. Biochem Soc Trans (1977) 0.97

The fate of 2,6-dimethoxy(U-14C)phenol in the rat. Xenobiotica (1974) 0.97

The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women. Xenobiotica (1983) 0.97

A recommended procedure for the estimation of bovine testicular hyaluronidase in the presence of human serum. Anal Biochem (1981) 0.96

Cigarette smoke--a proposed metabolic lesion in alveolar macrophages. Biochem Pharmacol (1972) 0.95

Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther (2001) 0.95

The metabolic fate of intravenously injected peptide-bound chondroitin sulphate in the rat. Biochem J (1976) 0.95

The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. J Pharmacol Exp Ther (1997) 0.94

A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes. Br J Clin Pharmacol (1988) 0.94

Detoxication of sodium 35 S-sulphide in the rat. Biochem Pharmacol (1972) 0.93

Dexamethasone metabolism in vitro: species differences. J Steroid Biochem Mol Biol (1997) 0.93

Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines. Biochem J (1975) 0.91

Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin. J Med Chem (2001) 0.91

Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis. J Pharmacol Exp Ther (1997) 0.91

The prognostic value of concurrent phrenic nerve palsy in newborn children with Erb's palsy. J Hand Surg Br (1998) 0.90

Neuroma-in-continuity resection: early outcome in obstetrical brachial plexus palsy. Plast Reconstr Surg (1998) 0.90

Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine. Xenobiotica (1995) 0.89

Modification of functional arginine residues in purified bovine testicular hyaluronidase with butane-2, 3-dione. Biochim Biophys Acta (1981) 0.89

The site of metabolism of potassium L-tyrosine O- 35 S-sulphate in the rat. Biochem Pharmacol (1969) 0.89

Preventing alcohol misuse: the impact of refusal skills and norms. Psychol Addict Behav (2000) 0.89

Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs. Chem Res Toxicol (1998) 0.89

Metabolic fates of diethylstilboestrol sulphates in the rat. Biochem J (1977) 0.89

The prognostic value of concurrent Horner's syndrome in total obstetric brachial plexus injury. J Hand Surg Br (2000) 0.89

Characteristics of eukaryotic initiation factor 2 and its subunits. J Biol Chem (1980) 0.88

Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether. J Med Chem (1999) 0.88

The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units. Br J Clin Pharmacol (1990) 0.88

Immunogenicity of amodiaquine in the rat. Int Arch Allergy Appl Immunol (1990) 0.87

Liver as major organ of phenol detoxication? Nature (1974) 0.87

2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine. Br J Clin Pharmacol (1984) 0.87

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Chem Res Toxicol (2001) 0.87

The biotransformation of 17 alpha-ethynyl[3H]estradiol in the rat: irreversible binding and biliary metabolites. Xenobiotica (1982) 0.87

Studies on the fate of pulmonary surfactant in the lung. Biochem J (1978) 0.86

The metabolic fate of chondroitin (35S)sulphate proteoglycan in the rat. Biochem Soc Trans (1975) 0.86

Molecular properties of radioiodinated apolipoprotein A-I. J Biol Chem (1984) 0.86

Evidence for filaggrin as a component of the cell envelope of the newborn rat. Biochem J (1988) 0.86

Comparison of the metabolism and toxicity of dapsone in rat, mouse and man. J Pharmacol Exp Ther (1997) 0.85

The preparation and characterization of a series of 35S-labelled aryl sulphate esters for metabolic studies. Biochem Pharmacol (1969) 0.85

Cortisol metabolism by human liver in vitro--I. Metabolite identification and inter-individual variability. J Steroid Biochem Mol Biol (1992) 0.85

Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase. Biochemistry (1974) 0.84

Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation. Chem Biol Interact (2000) 0.84

Drug protein conjugates--III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols. J Steroid Biochem (1983) 0.84

The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution. Biochem Pharmacol (1995) 0.84

Safety assessment of peroxide antimalarials: clinical and chemical perspectives. Br J Clin Pharmacol (1998) 0.83

Klumpke's birth palsy. Does it really exist? J Hand Surg Br (1995) 0.83

The biodegradation of the surfactant undecyl sulphate. Xenobiotica (1976) 0.83

Metabolism of sodium oestrone ( 35 S) sulphate in the guinea pig. Biochem J (1972) 0.83

Response to live attenuated measles vaccine in children with severe kwashiorkor. Ann Trop Paediatr (1982) 0.83

Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s). Drug Metab Dispos (1996) 0.83

Tissue distribution and excretion of amodiaquine in the rat. J Pharm Pharmacol (1988) 0.83